Drug Enforcement Administration
Federal agency responsible for regulations under Drug Enforcement Administration.
36 regulationsRegistering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017
This regulation allows emergency medical services (EMS) agencies like ambulance services and paramedic teams to register with the federal government so they can legally carry and use emergency medications. The rule makes it easier for first responders to access life-saving drugs quickly during emergencies without getting held up by complex federal drug registration rules.
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
The Drug Enforcement Administration is proposing to temporarily add 2-fluorodeschloroketamine, a newly created chemical similar to the drug ketamine, to the list of Schedule I controlled substances, which means it would be illegal to make, sell, or possess. This action is being taken because the drug has no approved medical use and poses public health risks.
Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents
The DEA is creating an official definition and classification system for cannabimimetic agents—chemicals that mimic the effects of cannabis but aren't technically cannabis itself. This rule aims to close loopholes that allow manufacturers to sell cannabis-like products legally by using synthetic or modified versions of the drug.
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
The Drug Enforcement Administration (DEA) has officially classified 4-fluoroamphetamine as an illegal drug in the most restrictive category, meaning it cannot be legally made, sold, or possessed in the United States. This action was taken because the drug poses serious health risks and is being misused as a street drug.
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
The Drug Enforcement Administration (DEA) has added two synthetic drugs called N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene to the list of Schedule I controlled substances, meaning they are now illegal to make, sell, or possess without a special license. These are powerful opioid-like drugs that have been linked to overdoses and deaths, and this ban aims to protect public health by preventing their distribution.
Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
The DEA is extending rules that allow doctors to prescribe certain controlled medications (like pain relievers and ADHD drugs) through video visits instead of requiring in-person appointments. This temporary extension keeps telemedicine prescribing options available for patients who may have difficulty traveling to doctor's offices.
Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
The Drug Enforcement Administration (DEA) has classified two synthetic drugs called N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene as Schedule I controlled substances, meaning they are now illegal to make, sell, or possess without special permission. These drugs are dangerous synthetic opioids that have caused overdoses and deaths, so the DEA is treating them the same way it treats heroin and other highly addictive drugs with no accepted medical use.
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
The Drug Enforcement Administration (DEA) is proposing to make four synthetic drugs—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—illegal by placing them in Schedule I, the highest level of drug restriction. This means these substances would be treated like heroin and LSD, with no legal medical use and serious criminal penalties for possession or distribution.
Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act
The DEA is extending its ban on four synthetic drugs (4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA) that were temporarily placed on the list of illegal controlled substances. These drugs are lab-made chemicals similar to marijuana and are dangerous designer drugs that were being sold illegally.
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
The Drug Enforcement Administration (DEA) is proposing to classify bromazolam, a dangerous synthetic drug, as a Schedule I controlled substance, which is the most restrictive category reserved for drugs with no medical use and high abuse potential. This means bromazolam would become illegal to manufacture, distribute, or possess without special permission, similar to heroin and LSD.
Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I
The Drug Enforcement Administration (DEA) is extending its ban on MDMB-4en-PINACA, a synthetic drug similar to marijuana, keeping it illegal for another period of time. This regulation prevents the drug from being sold or distributed while the DEA continues studying whether to make the ban permanent.
Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I
The Drug Enforcement Administration (DEA) is extending its temporary ban on CUMYL-PEGACLONE, a synthetic drug similar to K2 or spice, by keeping it classified as an illegal substance. This means the drug remains prohibited and people cannot legally make, sell, or possess it.